Avances terapéuticos en el tratamiento del cáncer de ovario: OLAPARIB: primer inhibidor de PARP - page 18

Kaufman B et al; J Clin Oncol 2015; Jan 20;33(3): 244-50S.

M. Domchek et al. Gynecologic Oncology 140 (2016) 199

–

203

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,8,9,10,11,12,13,14,15,16,17 19,20,21,22,23,24,25,26,27,28,...33